Chronic Treatment with Epidermal Growth Factor Induces Growth of the Rat Ventral Prostate

References

• Isaacs IT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate 1989; 2 (Suppl): 33–50.
   Google Scholar
• McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978; 15: 340–5.
   PubMedGoogle Scholar
• McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol Clin North Am 1990; 17: 477–86.
   PubMed Web of Science ®Google Scholar
• Cunha GR, Foster B, Thomson A, Sugimura Y, Tanji N, Tsuji M, et al. Growth factors as mediators of androgen action during the development of the male urogenital tract. World J Urol 1995; 13: 264–76.
   PubMed Web of Science ®Google Scholar
• Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract. Role of androgens, mesench-ymal-epithelial interactions, and growth factors. J Androl 1992; 13: 465–75.
   Google Scholar
• Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Mang J, et al. Regulation of prostatic growth and function by peptide growth factors. Prostate 1996; 28: 392–405.
   PubMed Web of Science ®Google Scholar
• Cunha GR, Donjacour AA, Cooke PS, Mee, S, Bigsby R1\4, Higgins SJ, et al. The endocrinology and develop-mental biology of the prostate. Endocr Rev 1987; 8: 338–62.
   PubMed Web of Science ®Google Scholar
• Sherwood ER, Lee C. Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol 1995; 13: 290–6.
   PubMed Web of Science ®Google Scholar
• Wu HIT, Kawamata H, Kawai K, Lee C, Oyasu R. Immunohistochemical localization of epidermal growth factor and transforming growth factor alpha in the male rat accessory sex organs. J Urol 1993; 150: 990–3.
   Google Scholar
• Itoh N, Patel U, Skinner MK. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells. Endocri-nology 1998; 139: 1369–77.
   Google Scholar
• TOrring N, JOrgensen PE, Poulsen SS, Nevi E. Epidermal growth factor in the rat prostate: production, tissue content and molecular forms in the different prostatic lobes. Prostate 1998; 35: 35–42.
   PubMed Web of Science ®Google Scholar
• Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 1993; 126: 151–8.
   Google Scholar
• Harper ME, Goddard L, Glynne Jones E, et al. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors. Prostate 1993;23: 9–23.in benign and malignant prostatic tumors. Prostate 1993;23: 9–23.
   Google Scholar
• McKeehan WL, Adams PS, Rosser MP. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 1984; 44: 1998–2010.
   Google Scholar
• Levine AC, Ren M, Huber GK, Kirschenbaum A. The effect of androgen, estrogen, and growth factors on the proliferation of cultured . broblasts derived from human fetal and adult prostates. Endocrinology 1992; 130: 2413–9.
   Google Scholar
• Tørring N, Sørensen BS, Boesch ST, Klocker H, Nexø E. Amphiregulin is expressed in primary cultures of prostate myo. broblasts, . broblasts, epithelial cells, and in prostate tissue. Prostate Cancer Prostatic Dis 1998; 5: 262–7.
   Web of Science ®Google Scholar
• Gupta C. The role of epidermal growth factor receptor (EGFR) in male reproductive tract differentiation: stimulation of EGFR expression and inhibition of Wolf. an duct differentiation with anti-EGFR antibody. Endocrinology 1996; 137: 905–10.
   Google Scholar
• Gupta C, Jaumotte J. Epidermal growth factor binding in the developing male reproductive duct and its regulation by testosterone. Endocrinology 1993; 133: 1778–82.
   PubMed Web of Science ®Google Scholar
• Matuo Y, Nishi N, Wada F. Growth factors in the prostate. Arch Androl 1987; 19: 193–210.
   PubMed Web of Science ®Google Scholar
• Tørring N, Vinter-Jensen L, Pedersen SB, Sørensen FB, Flyvbjerg A, Nexø E. Systemic administration of insulinlike growth factor I (IGF-I) causes growth of the rat prostate. J Urol 1997; 158: 222–7.
   PubMed Web of Science ®Google Scholar
• Taylor TB, Ramsdell JS. Transforming growth factoralpha and its receptor are expressed in the epithelium of the rat prostate gland. Endocrinology 1993; 133: 1306– 11.
   PubMed Web of Science ®Google Scholar
• Vinter-Jensen L, Smerup M, Jørgensen PE, et al. Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat. Urol Res 1996; 24: 15–21.
   Google Scholar
• Vinter-Jensen L. Pharmacological effects of epidermal growth factor (EGF) with focus on the urinary and gastrointestinal tracts. APMIS 1999; 93 (Suppl): 1–42.
   Google Scholar
• St Arnaud R, Poyet P, Walker P, Labrie F. Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate. Mol Cell Endocrinol 1988; 56: 21–7.
   PubMed Web of Science ®Google Scholar
• Marengo SR, Chung LW. An orthotopic model for the study of growth factors in the ventral prostate of the rat: effects of epidermal growth factor and basic . broblast growth factor. J Androl 1994; 15: 277–86.
   Google Scholar
• Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61: 1121–35.
   Google Scholar
• Gupta C. Modulation of androgen receptor (AR)- mediated transcriptional activity by EGF in the developing mouse reproductive tract primary cells. Mol Cell Endocrinol 1999; 152: 169–78.
   PubMed Web of Science ®Google Scholar
• Gupta C, Chandorkar A, Nguyen AP. Activation of androgen receptor in epidermal growth factor modulation of fetal mouse sexual differentiation. Mol Cell Endocrinol 1996; 123: 89–95.
   Google Scholar
• Tørring N, Vinter-Jensen L, Sørensen BS, Flyvbjerg A, Nexø E. Systemic treatment with epidermal growth factor (EGF) but not insulin-like growth factor I (IGF-I) decreases the involution of the prostate in castrated rats. Urol Res 2000; 28: 75–81.
   PubMedGoogle Scholar
• Sciarra F, Monti S, Adamo MV, Palma E, Toscano V, d’Eramo G, et al. Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue. Urol Res 1995; 23: 387–90.
   Google Scholar
• Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, et al. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with . nasteride or ’ utamide. J Androl 1997; 18: 488–94.
   PubMed Web of Science ®Google Scholar
• Di Silverio F, Sciarra A, Monti S, Casale P, Seccareccia F. Can the intraprostatic concentration of epidermal growth factor in’ uence the variance of serum prostate speci. c antigen levels in patients with benign prostatic hyperplasia? J Urol 1999; 161: 128–32.
   Google Scholar
• Gregory H, Willshire IR, Kavanagh JP, Blacklock NJ, Chowdury S, Richards RC. Urogastrone–epidermal growth factor concentrations in prostatic ’ uid of normal individuals and patients with benign prostatic hypertrophy. Clin Sci 1986; 70: 359–63.
   Web of Science ®Google Scholar
• Freeman MR, Paul S, Kaefer M, Ishikawa M, Adam RM, Renshaw AA, et al. Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. J Cell Biochem 1998; 68: 328–38.
   PubMed Web of Science ®Google Scholar
• Adam RM, Borer JG,Williams J, Eastham JA, Loughlin KR, Freeman MR. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factorlike growth factor in the interstitial smooth muscle of the human prostate. Endocrinology 1999; 140: 5866–75. Scand J
   Google Scholar